Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus mutans is a gram-positive bacterium recognized as the primary causative agent of dental caries. Its virulence is mediated by a complex array of metabolic enzymes and membrane proteins that facilitate the conversion of dietary sugars into lactic acid and the formation of a protective biofilm matrix. Key targets within this group include glucosyltransferases (GTFs), which produce extracellular glucans for adhesion, and the F-ATPase proton pump, which maintains intracellular pH in acidic environments (Lemos et al., 2019, Microbiol Spectr). Additionally, the phosphotransferase system (PTS) is responsible for the efficient uptake of various carbohydrates, fueling the bacterium's acidogenic nature. Therapeutic interventions often target these proteins to disrupt the cariogenic process; for instance, fluoride inhibits enolase and F-ATPase, while xylitol interferes with sugar transport via the PTS (NIH, StatPearls). Understanding these targets is essential for developing precision antimicrobials that can selectively inhibit S. mutans virulence without disrupting the healthy oral microbiome.
Inhibition of glucosyltransferases (GTFs) prevents the synthesis of extracellular polysaccharides (glucans), thereby reducing biofilm structural integrity (Lemos et al., 2019, Microbiol Spectr). Fluoride inhibits the glycolytic enzyme enolase and the F-ATPase proton pump, disrupting acid production and acid tolerance (NIH). Xylitol acts as a competitive inhibitor of the phosphotransferase system (PTS), leading to a futile metabolic cycle and energy depletion (PubMed). Chlorhexidine disrupts the bacterial cell membrane, leading to leakage of intracellular components (StatPearls).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial metabolic enzymes and membrane proteins in Streptococcus mutans.